Kontafarma China Holdings Limited is an investment holding company that manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally. It operates through the Pharmaceutical Business and Fitness Business segments, offering prescription drugs such as chemical drugs and prescribed traditional Chinese medicines, and running fitness and yoga centers, franchise operations, and management and consultation services for fitness and health activities. The company also provides corporate advisory services and conducts research and development of medical products. Formerly known as Tongfang Kontafarma Holdings Limited, it changed its name to Kontafarma China Holdings Limited in September 2022, was incorporated in 2011, and is headquartered in Wan Chai, Hong Kong. It is a subsidiary of Waranty Assets Management (Hk) Limited.